ArticleAntimicrobial agents and chemotherapy2017

Safety, Tolerability, Systemic Exposure, and Metabolism of CRS3123, a Methionyl-tRNA Synthetase Inhibitor Developed for Treatment of Clostridium difficile, in a Phase 1 Study.

Seema U Nayak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.